We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Multiparameter System Featuring Wearable Biosensor Enables Near Real-Time Patient Monitoring

By HospiMedica International staff writers
Posted on 03 Dec 2024
Print article
Image: The UbiqVue 2A Multiparameter System is based around a wearable ciosensor with chest-based SpO2 (Photo courtesy of LifeSignals)
Image: The UbiqVue 2A Multiparameter System is based around a wearable ciosensor with chest-based SpO2 (Photo courtesy of LifeSignals)

A novel cloud-based system featuring a wearable biosensor with chest-based SpO2 monitoring enables continuous patient monitoring across both hospital and out-of-hospital care settings.

The UbiqVue 2A Multiparameter System, developed by LifeSignals (Milpitas, CA, USA), represents a significant advancement in wireless, continuous patient monitoring for population health management. This system can be used in home, remote, and hospital environments to monitor patients’ physiological data in real time, improving patient safety and replacing traditional spot-check methods that can be labor-intensive and prone to inaccuracies. At the core of this system is the UbiqVue 2A Biosensor, a single-use, all-in-one wearable device designed to continuously collect SpO2 data from the chest. It also tracks a total of 12 other vital parameters, including 2-channel ECG, pulse rate, PPG, respiration rate, body temperature, and motion.

The data collected by the biosensor is encrypted and transmitted securely in near real-time via a relay app or access point to a secure cloud system, where it undergoes signal processing. Healthcare professionals and caregivers can access this continuous stream of vital signs from anywhere through the UbiqVue web portal and receive alert notifications. Designed to integrate seamlessly into clinical workflows, UbiqVue offers scalability across healthcare systems. Following its FDA Class II 510(k) clearance, the UbiqVue 2A Multiparameter System is set to revolutionize both individualized patient care and broader population health strategies.

"This FDA 510(k) approval marks a major milestone in LifeSignals' mission to deliver bedside patient monitor-like functionality through an affordable, single-use disposable Biosensor, enabling population health management," said Surendar Magar, Co-founder and CEO. "It shows our commitment to the vision of expanding the UbiqVue system with additional vital signs and advanced AI capabilities. Through global partnerships with OEMs, service providers, IDTFs, and distributors, we aim to transform healthcare at scale."

Related Links:
LifeSignals

Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
New
4K-3D NIR/ICG Video Endoscope
TIPCAM 1 Rubina
New
Vital Signs Monitor
iM3s

Print article

Channels

Surgical Techniques

view channel
Image: The Trilogy Valve with locator technology is the only TAVI system approved for aortic regurgitation (Photo courtesy of JenaValve)

New Transcatheter Valve Found Safe and Effective for Treating Aortic Regurgitation

Aortic regurgitation is a condition in which the aortic valve does not close properly, allowing blood to flow backward into the left ventricle. This results in decreased blood flow from the heart to the... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.